We use cookies and similar tools to give you the best website experience. By using our site, you accept our digital privacy statement.
Six months after PGCA may be too soon to identify prostate cancer persistence with PSA and MRI.
PSA reliably detects risk, even in men with end-stage kidney disease and liver failure, study finds.
Inadequate therapy raises risk of recurrence and poor outcomes.
Urology Highlights 2019–2020
Doctors treat patient using next-generation sequencing, targeted adjuvant therapy, and a neobladder.
Explore the Issue
We can help you find a doctor. Call 646-929-7800 or browse our specialists.
